abs385.txt	purpose		the	of	this	study	was	to	compare	outcomes	assessed	in	extantrandomized	controlled	trials	(rcts)	that	stakeholders	expect	fromsurvivorship	care	plans	(scps)	facilitate	transition	from	activetreatment	follow-up	for	15	5	million	us	cancer	survivors	manyorganizations	require	scp	use	however	results	several	rcts	scps'effectiveness	have	been	null	possibly	because	they	evaluated	onwhich	scps	should	be	expected	limited	influence	(e	g	oncologists)	may	differ	rcts'	methods	we	identified	using	a	pubmed	literature	review	weidentified	semistructuredinterviews	with	three	healthcare	systems	usa	and	canada	finally	mapped	onto	stakeholder-identified	rct	did	not	fully	address	expectedfrom	often	only	survivors'	perspectives	conclusions	scps'	effectiveness	thatstakeholders	better	understand	future	shouldassess	are	relevant	perspective	multiplestakeholders	implications	optimized	when	usedwith	an	eye	toward	means	as	map	guide	them	respect	what	kind	offollow-up	seek	it	whom	theyshould
